Tissue Net Receivables from 2010 to 2025
| TRX Stock | 58.50 1.50 2.50% |
Net Receivables | First Reported 2007-01-31 | Previous Quarter 4.3 M | Current Value 2.4 M | Quarterly Volatility 1.6 M |
Check Tissue Regenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tissue Regenix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 1 M or Selling General Administrative of 10.2 M, as well as many indicators such as . Tissue financial statements analysis is a perfect complement when working with Tissue Regenix Valuation or Volatility modules.
Tissue | Net Receivables |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Tissue Stock
Tissue Regenix financial ratios help investors to determine whether Tissue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tissue with respect to the benefits of owning Tissue Regenix security.